“The contract for each trial depends on the amount of work and the type of study,’’ says Cogstate chief executive Brad O’Connor.
A short phase-one study with only a few patients might be worth $200,000. At the other end, Cogstate has signed a $7.3 million for a global late-phase trial"
$$$
Blah
$$$
bsh
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.82 |
Change
0.040(2.25%) |
Mkt cap ! $308.9M | |||
| Open | High | Low | Value | Volume |
| $1.81 | $1.84 | $1.78 | $251.3K | 138.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 3206 | $1.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.81 | 105 | 1 |
View Market Depth
| Last trade - 15.40pm 22/07/2025 (20 minute delay) ? |
| CGS (ASX) Chart |